
Can China's Greater Bay Area Rival Tokyo And California?
Launched formally in 2017, the GBA initiative represents China's boldest experiment in economic integration and innovation-driven growth. But how does this ambitious regional bloc—home to 87 million people—stack up against established innovation hubs like Tokyo and San Francisco?
On a recent reporting trip, I met a delegation of young international professionals and academics as they wrapped up a week-long exploration through the GBA. Speaking to members of this diverse group offered me a unique window into the rapid transformations shaping the region and the perspectives of global professionals experiencing them firsthand.
Accelerated Progress, Complex Integration
China's ability to fast-track large-scale infrastructure is unmatched globally. Shenzhen's transformation into a bustling technological metropolis stands out particularly. Torry Ko, an Australian Senior Strategy Manager for Asia-Pacific at machine learning firm Moloco, described Shenzhen's development as 'one of the most significant transformations I've seen globally'.
Yet, speed can come at a cost. Unlike the organic growth seen in California or Tokyo, the GBA's centrally coordinated planning risks creating a patchwork of regulatory frameworks. Hong Kong, Macao, and mainland cities operate under vastly different laws, currencies, and governance structures, complicating seamless integration.
Pedro Henrique Steenhagen, a Brazilian PhD student in international politics at Fudan University, highlighted Macao's strategic potential as a link to Portuguese-speaking countries. But he cautioned that realizing such international ambitions depends on addressing administrative frictions that hinder cooperation across borders.
Balancing Corporate Power and Entrepreneurial Spirit
A major differentiator between the GBA and its counterparts in California and Tokyo lies in the foundations of their innovation ecosystems. Silicon Valley and Tokyo Bay thrive on grassroots entrepreneurship, academic research, and venture capital. The GBA primarily leverages the scale and prowess of established giants such as Tencent and medical technology leader Mindray.
Vanessa Marina Dias Herdade, Digital Solutions Manager at Carrefour Global Sourcing from Portugal, expressed admiration for the ambition and drive among local tech firms but noted that smaller enterprises remain overshadowed by corporate giants, restricting innovation diversity.
To mature fully, the GBA needs greater institutional support for entrepreneurship and stronger university-industry collaboration—a formula that sustains California's technological leadership.
Global Talent Attraction: Strengths and Limitations
The GBA's potential as a magnet for global talent is evident. The region offers professionals affordability, vibrant cities, and significant career opportunities. However, regulatory transparency and long-term stability remain areas of concern.
Ko praised Tencent's corporate culture as genuinely 'open and globally aware,' crucial in attracting international talent. Hugo Fontanel, a French senior manager at pharmaceutical company ViiV Healthcare, commended the digitization and ease of urban services in Shenzhen and Hong Kong, describing them as "impressive". Yet both emphasized that sustained global attraction hinges on clear legal frameworks and transparent residency paths.
Tanvir Parvez Matobbar, a Bangladeshi student leader at Tsinghua University, emphasized the diverse opportunities within the region itself, noting the potential to enhance global appeal through localized strengths.
A Future Beyond Infrastructure
Physically, the GBA is advancing rapidly, surpassing California's fragmented transit networks and even rivalling Tokyo's aging but extensive infrastructure. Visits to projects such as the Hong Kong-Zhuhai-Macao Bridge and the Hengqin New Area showcased significant connectivity improvements. However, Marcelina Liszewska, a Polish student in Asian studies, highlighted disparities among cities regarding governance and data privacy, potentially limiting cohesive regional growth.
Participants concluded that lasting success would require addressing deeper issues beyond infrastructure—social equity, environmental sustainability, and regulatory coherence.
Stefanie Tanya Jacqueline Spescha, a Swiss consultant and quantitative analyst at sustainability firm Sim2Sustain, emphasized the importance of institutions that nurture grassroots innovation and international collaboration, critical for the GBA's evolution.
Ultimately, the Greater Bay Area represents a unique hybrid—an unprecedented blend of central government ambition and local diversity. While it does not yet match Silicon Valley's entrepreneurial density or Tokyo's policy stability, the GBA's scale, rapid development, and state backing create enormous potential.
The region's true test lies ahead: Can it move beyond state-driven infrastructure toward a balanced ecosystem that supports grassroots creativity, global talent, and integrated innovation? If it succeeds, the Greater Bay Area may redefine what it means to be a global innovation hub in the 21st century.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Gizmodo
30 minutes ago
- Gizmodo
Billionaires Convince Themselves AI Is Close to Making New Scientific Discoveries
Generative artificial intelligence tools like ChatGPT, Gemini, and Grok have exploded in popularity as AI becomes mainstream. These tools don't have the ability to make new scientific discoveries on their own, but billionaires are convinced that AI is on the cusp of doing just that. And the latest episode of the All-In podcast helps explain why these guys think AI is extremely close to revolutionizing scientific knowledge. Travis Kalanick, the founder of Uber who no longer works at the company, appeared on All-In to talk with hosts Jason Calacanis and Chamath Palihapitiya about the future of technology. When the topic turned to AI, Kalanick discussed how he uses xAI's Grok, which went haywire last week, praising Adolf Hitler and advocating for a second Holocaust against Jews. 'I'll go down this thread with [Chat]GPT or Grok and I'll start to get to the edge of what's known in quantum physics and then I'm doing the equivalent of vibe coding, except it's vibe physics,' Kalanick explained. 'And we're approaching what's known. And I'm trying to poke and see if there's breakthroughs to be had. And I've gotten pretty damn close to some interesting breakthroughs just doing that.' The guys on the podcast only briefly addressed Grok's failures without getting into specifics about the MechaHitler debacle, and none of that stopped Kalanick from talking like Grok was this revolutionary tool that was so close to making scientific discoveries in revolutionary ways. 'I pinged Elon on at some point. I'm just like, dude, if I'm doing this and I'm super amateur hour physics enthusiast, like what about all those PhD students and postdocs that are super legit using this tool?' Kalanick said. Kalanick suggested that what made this even more incredible was that he was using an earlier version of Grok before Grok 4 was released on Wednesday. 'And this is pre-Grok 4. Now with Grok 4, like, there's a lot of mistakes I was seeing Grok make that then I would correct, and we would talk about it. Grok 4 could be this place where breakthroughs are actually happening, new breakthroughs,' Kalanick said. Calacanis asked Kalanick the obvious question of whether Grok was actually on the verge of a scientific breakthrough. Because anyone who actually understands large language models knows that it can't achieve new ways of thinking. It's just putting together words in the most statistically likely way, forming connections that may sound like a well-thought-out argument but are actually not a form of true 'intelligence' as humans would define it. 'Is your perception that the LLMs are actually starting to get to the reasoning level, that they'll come up with a novel concept theory and have that breakthrough? Or that we're kind of reading into it and it's just trying random stuff at the margins?' Calacanis asked. Kalanick said that he hasn't used Grok 4 because he was having technical difficulties accessing it, suggesting that perhaps a later version of Grok might be capable of such a thing. But he admitted the AI couldn't yet come up with new discoveries. 'No, it cannot come up with the new idea. These things are so wedded to what is known. And they're so like, even when I come up with a new idea, I have to really, it's like pulling a donkey. You see, you're pulling it because it doesn't want to break conventional wisdom. It's like really adhering to conventional wisdom. You're pulling it out and then eventually goes, oh, shit, you got something,' Kalanick said. Kalanick emphasized that 'you have to double and triple check to make sure that you really got something,' making clear he understood that AI chatbots just make things up much of the time. But he still seemed convinced that the thing holding back Grok was 'conventional wisdom' rather than the natural limitations of the tech. Palihapitiya went a step further than Kalanick, insisting that synthetic data could train new AI models. 'When these models are fully divorced from having to learn on the known world and instead can just learn synthetically, then everything gets flipped upside down to what is the best hypothesis you have or what is the best question? You could just give it some problem and it would just figure it out,' Palihapitiya. Musk revealed a similar line of thinking recently when he suggested 'general artificial intelligence' was close because he had asked Grok 'about materials science that are not in any books or on the Internet.' The idea, of course, is that Musk had hit the limits of known science rather than the limit of his scientific understanding. The billionaire really seems convinced that Grok was working on something new. That was how I felt when asking Grok 4 questions about materials science that are not in any books or on the Internet — Elon Musk (@elonmusk) July 10, 2025These guys are hyping up the idea of general artificial intelligence (AGI), which doesn't even have an exact definition. But it's far from the only term getting tossed around right now. AI folks also drop words like 'superintelligence' without defining what that means, but it sure keeps the investors intrigued. These AI chatbots are pulling off a magic trick. They can often seem like they're 'thinking' or applying rational thought to a given answer, but they work by spitting out the next word that's most likely to be next in a sentence, not by actually applying critical reasoning. There's a reason that people who understand AI the best are the least excited about using it. Apple has gotten a lot of shit for not committing to AI in a more forceful way, something the All-In guys talked about, but the company understands perhaps better than most that there are limitations to this tech. In fact, Apple released a paper last month that shows how Large Reasoning Models (LRMs) struggle, facing 'a complete accuracy collapse beyond certain complexities.' Apple's paper won't dampen the hype, of course. Just about every other major tech company is pushing hard into AI agents and investing billions of dollars into data centers. Meta CEO Mark Zuckerberg announced Monday that his company was building enormous new data centers to work on superintelligence. 'Meta Superintelligence Labs will have industry-leading levels of compute and by far the greatest compute per researcher,' Zuck wrote. 'I'm looking forward to working with the top researchers to advance the frontier!'
Yahoo
30 minutes ago
- Yahoo
Sino Biopharma spends $951m to acquire China-based LaNova Medicines
Hong Kong-listed Sino Biopharmaceutical will acquire China-based oncology specialist LaNova Medicines in a deal that will not exceed $951m, representing one of the largest transactions within the Asia-Pacific pharmaceutical arena this year. Sino already owns a 4.91% stake courtesy of an investment in November 2024, with the company now seeking to purchase the remaining 95.09% it does not own. At the time, Sino spent 142 million yuan ($19.80m) to initiate its ownership involvement with the biotech. The net payment made by Sino to acquire LaNova will be approximately $500.9m, a figure that excludes the estimated cash and bank deposits, according to a company document outlining the terms of the transaction. Following the completion of the nearly billion-dollar deal, LaNova Medicines will become an indirect wholly owned subsidiary of Sino. A timeline of 30 business days has been set by the companies to finalise the deal. Sino revealed the acquisition agreement after trading hours on 15 July. The share price in the company had climbed 3.6% by market close. LaNova's drug development focuses on tumour immunity and the tumour microenvironment. The company has particular emphasis on antibody-drug conjugates (ADCs) and has built several platforms within this modality. Sino stated the acquisition would strengthen its research and development capabilities, subsequently enhancing competitiveness and innovation in the oncology market. LaNova's pipeline has already been raided twice by US big pharma companies. In 2023, AstraZeneca licensed LM-305, a G-protein targeting-ADC, for $600m. A year later, MSD outlaid more than $3bn to secure global rights to LM-299, an anti-PD-1/VEGF bispecific antibody. According to Sino, LaNova Medicines has two projects in the registration clinical stage, six projects in the Phase I/II clinical trial stage, and more than ten projects in the preclinical research stage. In a statement, Sino said: 'Through the in-depth synergy and integration of the advantageous resources of both parties, not only will the potential value of LaNova Medicines be fully released, but also [Sino's] innovation capability will be comprehensively enhanced." The company added that the transaction will help towards its 'strategic goal of advancing towards a world-class innovative pharmaceutical enterprise'. China's economy grew 5.2% year-on-year in Q2, defying the lingering effects of US President Trump's trade war and reinforcing its position as the world's top exporter. This economic resilience is mirrored in China's growing role in the global oncology market. Despite economic pressures, licensing promising drug candidates from Chinese biotechs is becoming a well-trodden path for many US big pharma companies. Licensing deals between US and Chinese biopharma companies hit record highs last year, a 280% increase from 2020, according to analysis by GlobalData. Across big pharma, transactions rose 66% from $16.6bn in 2023 to $41.5bn in 2024, demonstrating that China is still the go-to place to discover pipeline candidates. For deals specific to US companies, the analysis found that total deal value rose from $15.7bn in 2023 to $21.3bn in 2024. GlobalData is the parent company of Pharmaceutical Technology. "Sino Biopharma spends $951m to acquire China-based LaNova Medicines" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
30 minutes ago
- Yahoo
Dollar Rallies on Higher T-note Yields
The dollar index (DXY00) today is up +0.47%. The dollar is seeing support as the 10-year T-note rose +3.6 bp and the 30-year T-bond yield rose back above 5% for the first time in 1.5 months. The rise in Treasury yields supported the dollar's interest rate differentials. Today's US CPI report generated some favorable initial media coverage as the June core CPI report of +0.2% m/m was slightly below expectations of +0.3%. However, there were some scattered signs of upside pressure from tariffs, and that pressure is expected to increase in the coming months. Also, both the headline and core CPI reports on a year-over-year basis rose from May. Latest US Tariff Threats Boost the Dollar Dollar Supported by Latest US Tariff Threats Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! Specifically, the June US CPI rose +0.3% m/m, which was in line with market expectations, while the year-over-year figure of +2.7% was slightly worse than expectations of +2.6% and was up from May's +2.4%. The June US core CPI rose +0.2% m/m, which was slightly better than expectations of +0.3%. On a year-over-year basis, the June US core CPI was in line with expectations at +2.9% y/y but rose from May's +2.8%. Today's CPI report did not improve market expectations for Fed easing, which were little changed after the CPI report. Federal funds futures prices are discounting the chances for a -25 bp rate cut at 3% at the July 29-30 FOMC meeting and at 65% at the following meeting on Sep 16-17. There was some positive trade news today after Treasury Secretary Bessent said that US-China trade talks are in a "very good place," which reduced safe-haven demand for the dollar. He also said the US-China deadline is flexible and told market participants "not to worry about August 12." Mr. Bessent confirmed that the Trump administration has told Nvidia that a license for the sale of its advanced H20 GPU chips to Chinese firms will be granted and is "all part of a mosaic" in the US-China negotiations. He also said he hopes to meet with Chinese Vice Premier He Lifeng in August. EUR/USD (^EURUSD) is down -0.36% on strength in the dollar. The euro was also undercut by today's -2.4 bp decline in the 10-year bund yield, which reduced the euro's interest rate differentials. The euro saw underlying support from news that the July German ZEW expectations index rose +5.2 points to 52.7 from 47.5 in June, which was stronger than expectations for an increase to 50.4. The euro also saw underlying support as the May Eurozone industrial production report of +1.7% m/m and +3.7% y/y was stronger than market expectations of +1.0% m/m and +2.2% y/y. Swaps are pricing in a 2% chance of a -25 bp rate cut by the ECB at the July 24 policy meeting. USD/JPY (^USDJPY) is up +0.76% on dollar strength. Additionally, the yen remains under pressure due to concerns about the upcoming upper house election in Japan on July 20. The promises by Japan's ruling Liberal Democratic Party of cash handouts to voters and promises of lower taxes by the opposition have sparked concerns of fiscal deterioration, which are bearish for the yen. August gold (GCQ25) is down -2.2 (-0.07%), and September silver (SIU25) is down -0.402 (-1.04%). Precious metals are trading lower on today's +0.47% rise in the dollar index and the +3.6 bp rise in the 10-year T-note yield. Sep silver is seeing some long liquidation after falling back from Monday's contract high. July 2025 silver today fell back from Monday's 14-year high on the nearest-futures chart. Precious metals prices also fell back today on some favorable trade news as Treasury Secretary Bessent claimed that US-Chinese trade talks were in a "very good place." On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data